COMP <GO>
INSP vs UNH // 10Y YIELD & FRED MACRO BETA
Inspire Medical Systems Inc. (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: INSP 5
— UNH 7
■ METRIC PARITY
LAST: $71.18 (+0.30%) • MKT CAP: $2.06B
macro-sensitivity
—
LAST: $410.91 (+0.94%) • MKT CAP: $368.83B
macro-sensitivity
0.33
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (INSP VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | INSP | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 85.40% | 88.57% | -3.17 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.00% | 11.47% | -5.47 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 23.3x | 16.4x | +6.85 | UNH | /valuation <GO> |
| Free Cash Flow Yield | 3.81% | 6.48% | -2.67 | UNH | /fcf-yield <GO> |
| Operating Margin | 5.60% | 4.82% | +0.78 | INSP | /operating-margins <GO> |
| Net Profit Margin | 15.90% | 3.14% | +12.76 | INSP | /net-margins <GO> |
| Revenue Growth (YoY) | 13.60% | 6.46% | +7.14 | INSP | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 11.40 | 3.12 | +8.28 | INSP | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.74% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 45.4 | 59.2 | -13.85 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | 0.33 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 11.9x | 17.1x | -5.19 | INSP | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.06B | $368.83B | -$366.77B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | INSP REV | UNH REV | INSP GROSS % | UNH GROSS % | INSP FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $912.0M | $447.57B | 85.4% | 88.7% | $78.5M | $16.07B |
| FY 2024 | $802.8M | $400.28B | 84.7% | 88.3% | $91.1M | $20.70B |
| FY 2023 | $624.8M | $371.62B | — | 89.6% | $24.7M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
INSP // BETA —
UNH // BETA 0.33